Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
2031.2000
-20.60
(
-1.00
%)
NSE
Sep 17, 2025
15:31 PM
Volume:
672.3K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
29 Oct 2021
US FDA Observation
2031.20
-1.00%
Lupin Ltd
Hold:
Lupin Ltd.
by
ICICI Securities Limited
Target: 1015
Target
ICICI Securities Limited
Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
More from Lupin Ltd.
Recommended
From gems to gadgets: India’s $24 billion leap into global smartphone manufacturing
The Baseline |
17 Sep 2025, 06:26PM
Market closes higher, Authum Investment acquires a 3% stake in Serovia Pharma for Rs 300 crore
Trendlyne Marketwatch |
17 Sep 2025, 03:58PM
Lupin expects normalization by September quarter
|
17 Apr 2020, 02:22PM